I. Agency, . Research, and . Cancer, GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012

J. Neoptolemos, D. Stocken, J. Dunn, J. Almond, H. Beger et al., Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial, Annals of Surgery, vol.234, issue.6, pp.758-68, 2001.
DOI : 10.1097/00000658-200112000-00007

H. Oettle, S. Post, and P. Neuhaus, Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer, JAMA, vol.297, issue.3, pp.267-77, 2007.
DOI : 10.1001/jama.297.3.267

J. Neoptolemos, D. Stocken, C. Bassi, P. Ghaneh, D. Cunningham et al., Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection, JAMA, vol.304, issue.10, pp.1073-81, 2010.
DOI : 10.1001/jama.2010.1275

H. Oettle, P. Neuhaus, A. Hochhaus, J. Hartmann, K. Gellert et al., Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer, JAMA, vol.310, issue.14, pp.1473-81, 2013.
DOI : 10.1001/jama.2013.279201

G. Fuhrman, S. Leach, C. Staley, J. Cusack, C. Charnsangavej et al., Rationale for En Bloc Vein Resection in the Treatment of Pancreatic Adenocarcinoma Adherent to the Superior Mesenteric-Portal Vein Confluence, Annals of Surgery, vol.223, issue.2, pp.154-62, 1996.
DOI : 10.1097/00000658-199602000-00007

P. Bachellier, H. Nakano, P. Oussoultzoglou, J. Weber, K. Boudjema et al., Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?, The American Journal of Surgery, vol.182, issue.2, pp.120-129, 2001.
DOI : 10.1016/S0002-9610(01)00686-9

N. Carrère, A. Sauvanet, D. Goere, R. Kianmanesh, M. Vullierme et al., Pancreaticoduodenectomy with Mesentericoportal Vein Resection for Adenocarcinoma of the Pancreatic Head, World Journal of Surgery, vol.7, issue.8, pp.1526-1561, 2006.
DOI : 10.1001/archsurg.1995.01430030065013

E. Yekebas, D. Bogoevski, G. Cataldegirmen, C. Kunze, A. Marx et al., En Bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood Vessels, Annals of Surgery, vol.247, issue.2, pp.300-309, 2008.
DOI : 10.1097/SLA.0b013e31815aab22

S. Müller, M. Hartel, A. Mehrabi, T. Welsch, D. Martin et al., Vascular Resection in Pancreatic Cancer Surgery: Survival Determinants, Journal of Gastrointestinal Surgery, vol.93, issue.10, pp.784-92, 2009.
DOI : 10.1016/j.ejso.2007.01.022

M. Ouaissi, C. Hubert, R. Verhelst, P. Astarci, C. Sempoux et al., Vascular Reconstruction During Pancreatoduodenectomy for Ductal Adenocarcinoma of the Pancreas Improves Resectability but does not Achieve Cure, World Journal of Surgery, vol.26, issue.3, pp.2648-61, 2010.
DOI : 10.1016/j.jamcollsurg.2007.10.002

O. Turrini, J. Ewald, L. Barbier, D. Mokart, J. Blache et al., Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg, avr, vol.257, issue.4, pp.726-756, 2013.

M. Tempero, M. Malafa, S. Behrman, A. Benson, E. Casper et al., Pancreatic Adenocarcinoma, Version 2.2014, Journal of the National Comprehensive Cancer Network, vol.12, issue.8, pp.1083-93, 2014.
DOI : 10.6004/jnccn.2014.0106

M. Bockhorn, F. Uzunoglu, M. Adham, C. Imrie, M. Milicevic et al., Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS), Surgery, vol.155, issue.6, pp.977-88, 2014.
DOI : 10.1016/j.surg.2014.02.001

F. Campbell, A. Foulis, and C. Verbeke, The Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct, 2010.

Y. Zhou, Z. Zhang, Y. Liu, B. Li, and D. Xu, Pancreatectomy Combined with Superior Mesenteric Vein???Portal Vein Resection for Pancreatic Cancer: A Meta-analysis, World Journal of Surgery, vol.142, issue.4, pp.884-91, 2012.
DOI : 10.1001/archsurg.142.2.172

R. Ravikumar, C. Sabin, A. Hilal, M. Bramhall, S. White et al., Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study, Journal of the American College of Surgeons, vol.218, issue.3, pp.401-412, 2014.
DOI : 10.1016/j.jamcollsurg.2013.11.017

R. Poon, S. Fan, C. Lo, C. Liu, C. Lam et al., Pancreaticoduodenectomy with En Bloc Portal Vein Resection for Pancreatic Carcinoma with Suspected Portal Vein Involvement, World Journal of Surgery, vol.28, issue.6, pp.602-610, 2004.
DOI : 10.1007/s00268-004-7250-6

J. Tseng, C. Raut, J. Lee, P. Pisters, J. Vauthey et al., Pancreaticoduodenectomy with vascular resection: margin status and survival duration, Journal of Gastrointestinal Surgery, vol.8, issue.8, pp.935-984, 2004.
DOI : 10.1016/j.gassur.2004.09.046

X. Yu, J. Li, D. Fu, Y. Di, F. Yang et al., Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis, European Journal of Surgical Oncology (EJSO), vol.40, issue.4, pp.371-379, 2014.
DOI : 10.1016/j.ejso.2014.01.010

Y. Murakami, K. Uemura, T. Sudo, Y. Hashimoto, A. Nakashima et al., Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma, Journal of Surgical Oncology, vol.40, issue.4, pp.414-435, 2013.
DOI : 10.1093/jjco/hyq011

H. Riediger, F. Makowiec, E. Fischer, U. Adam, and U. Hopt, Postoperative Morbidity and Long-term Survival After Pancreaticoduodenectomy With Superior Mesenterico???Portal Vein Resection, Journal of Gastrointestinal Surgery, vol.10, issue.8, pp.1106-1121, 2006.
DOI : 10.1016/j.gassur.2006.04.002

S. Han, S. Park, S. Kim, S. Cho, Y. Kim et al., Clinical Significance of Portal-Superior Mesenteric Vein Resection in Pancreatoduodenectomy for Pancreatic Head Cancer, Pancreas, vol.41, issue.1, pp.102-108, 2012.
DOI : 10.1097/MPA.0b013e318221c595

A. Rehders, N. Stoecklein, A. Güray, R. Riediger, A. A. Knoefel et al., Vascular invasion in pancreatic cancer: Tumor biology or tumor topography?, Surgery, vol.152, issue.3, pp.143-51, 2012.
DOI : 10.1016/j.surg.2012.05.012

S. Fukuda, E. Oussoultzoglou, P. Bachellier, E. Rosso, H. Nakano et al., Significance of the Depth of Portal Vein Wall Invasion After Curative Resection for Pancreatic Adenocarcinoma, Archives of Surgery, vol.142, issue.2, pp.172-181, 1960.
DOI : 10.1001/archsurg.142.2.172

Y. Murakami, S. Satoi, F. Motoi, M. Sho, M. Kawai et al., Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma, British Journal of Surgery, vol.240, issue.7, 2015.
DOI : 10.1097/01.sla.0000133083.54934.ae

C. Kurihara, F. Yoshimi, K. Sasaki, K. Nakao, T. Kawasaki et al., Impact of portal vein invasion and resection length in pancreatoduodenectomy on the survival rate of pancreatic head cancer, Hepatogastroenterology. oct, vol.60, issue.127, pp.1759-65, 2013.

A. Nakao, A. Kanzaki, T. Fujii, Y. Kodera, S. Yamada et al., Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer, Annals of Surgery, vol.255, issue.1, pp.103-111, 2012.
DOI : 10.1097/SLA.0b013e318237872e

T. Ichikawa, S. Erturk, H. Sou, H. Nakajima, T. Tsukamoto et al., MDCT of Pancreatic Adenocarcinoma: Optimal Imaging Phases and Multiplanar Reformatted Imaging, American Journal of Roentgenology, vol.187, issue.6, pp.1513-1533, 2006.
DOI : 10.2214/AJR.05.1031

J. Wong and D. Lu, Staging of Pancreatic Adenocarcinoma by Imaging Studies, Clinical Gastroenterology and Hepatology, vol.6, issue.12, pp.1301-1309, 2008.
DOI : 10.1016/j.cgh.2008.09.014

D. Halperin, G. Varadhachary, and . Resectable, Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?, Current Oncology Reports, vol.14, issue.4, pp.1-9, 2014.
DOI : 10.1097/CJI.0b013e3181eec14c

P. Michl, S. Pauls, and T. Gress, Evidence-based diagnosis and staging of pancreatic cancer, Best Practice & Research Clinical Gastroenterology, vol.20, issue.2, pp.227-51, 2006.
DOI : 10.1016/j.bpg.2005.10.005

M. Hidalgo, Pancreatic Cancer, New England Journal of Medicine, vol.362, issue.17, pp.1605-1622, 2010.
DOI : 10.1056/NEJMra0901557

G. Ramacciato, P. Mercantini, N. Petrucciani, V. Giaccaglia, G. Nigri et al., Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma?, Annals of Surgical Oncology, vol.41, issue.4, pp.817-842, 2009.
DOI : 10.1007/s00268-007-9015-5

M. Sho, T. Akahori, T. Tanaka, S. Kinoshita, M. Nagai et al., Importance of resectability status in neoadjuvant treatment for pancreatic cancer, Journal of Hepato-Biliary-Pancreatic Sciences, vol.21, issue.7, 2015.
DOI : 10.1002/jhbp.130

F. Polistina, D. Natale, G. Bonciarelli, G. Ambrosino, G. Frego et al., Neoadjuvant strategies for pancreatic cancer, World J Gastroenterol WJG. 28 juill, vol.20, issue.28, pp.9374-83, 2014.

J. Sutton and D. Abbott, Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies, World Journal of Gastroenterology, vol.20, issue.42, pp.15564-79, 2014.
DOI : 10.1002/jso.21527

S. Heinrich, B. Pestalozzi, M. Lesurtel, F. Berrevoet, S. Laurent et al., Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study), BMC Cancer, vol.8, issue.19, p.346, 2011.
DOI : 10.1186/1471-2407-8-82

D. Chang, A. Johns, N. Merrett, A. Gill, E. Colvin et al., Margin Clearance and Outcome in Resected Pancreatic Cancer, Journal of Clinical Oncology, vol.27, issue.17, pp.2855-62, 2009.
DOI : 10.1200/JCO.2008.20.5104

N. Jamieson, N. Chan, A. Foulis, E. Dickson, C. Mckay et al., The Prognostic Influence of Resection Margin Clearance Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma, Journal of Gastrointestinal Surgery, vol.38, issue.3, pp.511-532, 2013.
DOI : 10.1016/j.ejso.2011.12.015

I. Esposito, J. Kleeff, F. Bergmann, C. Reiser, E. Herpel et al., Most Pancreatic Cancer Resections are R1 Resections, Annals of Surgical Oncology, vol.92, issue.6, pp.1651-60, 2008.
DOI : 10.1007/3-540-27449-9_5

F. Campbell, R. Smith, P. Whelan, R. Sutton, M. Raraty et al., Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1???mm of a resection margin, Histopathology, vol.27, issue.18 suppl (abstr, pp.277-83, 2009.
DOI : 10.1111/j.1365-2559.2009.03376.x

M. Wagner, C. Redaelli, M. Lietz, C. Seiler, H. Friess et al., Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma, British Journal of Surgery, vol.91, issue.5, pp.586-94, 2004.
DOI : 10.1002/bjs.4484

J. Lüttges, I. Vogel, M. Menke, D. Henne-bruns, B. Kremer et al., The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas, Virchows Archiv, vol.433, issue.3, pp.237-279, 1998.
DOI : 10.1007/s004280050242

J. Delpero, F. Paye, and P. Bachellier, Cancer du pancréas: rapport présenté au 112e Congrès français de chirurgie, Paris, 6 -8 octobre 2010, 2010.